Search
Close this search box.

Day: November 7, 2024

Zenas BioPharma to Participate in Upcoming Healthcare Investor Conferences

WALTHAM, Mass, Nov. 07, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies, today announced the Company’s participation at the following healthcare investor conferences: Guggenheim’s Inaugural Healthcare

Nyxoah Reports Third Quarter Financial and Operating Results

REGULATED INFORMATION Nyxoah Reports Third Quarter Financial and Operating Results FDA approval on track for first quarter 2025, U.S. commercial team build out in progress Company fully funded with cash until mid 2026 Mont-Saint-Guibert, Belgium – November 6, 2024, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)

Qatari Aircraft Delivers Essential Aid to Lebanon Amid Crisis.

Beirut: A Qatari Amiri Air Force aircraft arrived Thursday at Rafic Hariri International Airport, carrying relief aid and shelter supplies, within the framework of the cooperation between the Ministry of Foreign Affairs and the United Nations High Com…

Recent post's